Farzan Clinical Research Organization has started its work since 2008. This center is the first Iranian clinical research organization. Clinical research organizations (CROs) are contractors for drug studies, clinical trials (including phases 1 to 4 of clinical trials), and registry and epidemiologic studies for pharmaceutical companies.
Farzan Clinical Research Organization is approved by the Food and Drug Organization. The major research and business partners of this institute have been the world’s major pharmaceutical companies and clinical research organizations of other countries. This center has more than 30 international agreements and memorandums of understanding with countries from Europe, Asia and Africa.
Working with the most prestigious international pharmaceutical companies requires achieving the highest level of research standards achieved at Farzan Institute. This center has standard operating Procedures (SOP) for all its processes, including clinical research and data management and monitoring of research results.
This institute has been approved by the Vice President of Science and Technology as a knowledge-based export company.
So far, Farzan Institute has concluded about 4000 research contracts with Iranian universities and research centers and has published 510 articles in the world’s most prestigious medical journals up to an impact factor (IF) level of 160. Articles published by mentioning the name of this institution are mentioned on the website of the World Health Organization (WHO). Also, the publication of thousands of pages of medical books and obtaining various titles such as university year book, student year book and selected book from various festivals are among the activities of this institution. The electronic training system of this institution includes 620 thousand users and 420 titles of training courses.
The Farzan Clinical Research Organization website can be accessed and used at https://cro.farzaninstitute.com.